Literature DB >> 34282213

Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension.

Kewal Asosingh1,2, Suzy Comhair3, Lori Mavrakis3, Weiling Xu3, Dean Horton4, Ian Taylor5, Svyatoslav Tkachenko6, Bo Hu6, Serpil Erzurum7,8.   

Abstract

Pulmonary arterial hypertension (PAH) is an insidious disease characterized by severe remodeling of the pulmonary vasculature caused in part by pathologic changes of endothelial cell functions. Although heterogeneity of endothelial cells across various vascular beds is well known, the diversity among endothelial cells in the healthy pulmonary vascular bed and the pathologic diversity among pulmonary arterial endothelial cells (PAEC) in PAH is unknown and previously unexplored. Here single-cell RNA sequencing technology was used to decipher the cellular heterogeneity among PAEC in the human pulmonary arteries isolated from explanted lungs from three patients with PAH undergoing lung transplantation and three healthy donor lungs not utilized for transplantation. Datasets of 36,368 PAH individual endothelial cells and 36,086 healthy cells were analyzed using the SeqGeq bioinformatics program. Total population differential gene expression analyses identified 629 differentially expressed genes between PAH and controls. Gene Ontology and Canonical Ingenuity analysis revealed pathways that are known to be involved in pathogenesis, as well as unique new pathways. At the individual cell level, dimensionality reduction followed by density based clustering revealed the presence of eight unique PAEC clusters that were typified by proliferative, angiogenic or quiescent phenotypes. While control and PAH harbored many similar subgroups of endothelial cells, PAH had greater proportions of angiogenic and proliferative subsets. These findings identify that only specific subgroups of PAH PAEC have gene expression different than healthy PAEC, and suggest these subpopulations lead to the pathologic functions leading to remodeling.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34282213     DOI: 10.1038/s41598-021-94163-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

Review 1.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Phenotypic heterogeneity of the endothelium: II. Representative vascular beds.

Authors:  William C Aird
Journal:  Circ Res       Date:  2007-02-02       Impact factor: 17.367

Review 3.  Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms.

Authors:  William C Aird
Journal:  Circ Res       Date:  2007-02-02       Impact factor: 17.367

4.  Alterations of cellular bioenergetics in pulmonary artery endothelial cells.

Authors:  Weiling Xu; Thomas Koeck; Abigail R Lara; Donald Neumann; Frank P DiFilippo; Michelle Koo; Allison J Janocha; Fares A Masri; Alejandro C Arroliga; Constance Jennings; Raed A Dweik; Rubin M Tuder; Dennis J Stuehr; Serpil C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 5.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

6.  Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.

Authors:  Iwona Fijalkowska; Weiling Xu; Suzy A A Comhair; Allison J Janocha; Lori A Mavrakis; Balaji Krishnamachary; Lijie Zhen; Thianzi Mao; Amy Richter; Serpil C Erzurum; Rubin M Tuder
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

7.  Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.

Authors:  Micheala A Aldred; Suzy A Comhair; Marileila Varella-Garcia; Kewal Asosingh; Weiling Xu; George P Noon; Patricia A Thistlethwaite; Rubin M Tuder; Serpil C Erzurum; Mark W Geraci; Christopher D Coldren
Journal:  Am J Respir Crit Care Med       Date:  2010-06-25       Impact factor: 21.405

Review 8.  Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.

Authors:  Weiling Xu; Serpil C Erzurum
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

9.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.

Authors:  Weiling Xu; F Takao Kaneko; Shuo Zheng; Suzy A A Comhair; Allison J Janocha; Tannishia Goggans; Frederik B J M Thunnissen; Carol Farver; Stanley L Hazen; Constance Jennings; Raed A Dweik; Alejandro C Arroliga; Serpil C Erzurum
Journal:  FASEB J       Date:  2004-09-13       Impact factor: 5.191

10.  Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension.

Authors:  Fares A Masri; Weiling Xu; Suzy A A Comhair; Kewal Asosingh; Michelle Koo; Amit Vasanji; Judith Drazba; Bela Anand-Apte; Serpil C Erzurum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-05-25       Impact factor: 5.464

View more
  1 in total

1.  Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.

Authors:  Guangyan Zhang; Yin Kang; Sheng Wang; Jiapeng Huang; Bradley B Keller; Dakotah Cathey; Amanda J LeBlanc; Jun Cai; Lu Cai
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-14       Impact factor: 3.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.